Plus   Neg

Endocyte Inc. (ECYT) Has Jumped To A New High After Bought By Novartis

Endocyte Inc. (ECYT) announced Thursday morning that it has agreed to be acquired by Novartis for $24 per share in cash, or approximately $2.1 billion.

Endocyte has gapped open sharply higher this morning and is now up 7.81 at $23.37 on the highest volume in 7 1/2 months. The stock has leaped to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT